Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
Public ClinicalTrials.gov record NCT07502495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets Despite Antihyperglycemic Medications
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2, randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of icovamenib in participants with Type 2 Diabetes who are not achieving glycemic targets despite antihyperglycemic medications.
Study identification
- NCT ID
- NCT07502495
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 27, 2026 (Actual)
- Primary completion
- Mar 2027 (Estimated)
- Completion
- Sep 2027 (Estimated)
- Last update posted
- Aug 28, 2026
2026 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 8
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Research Associates, LLC dba Flourish Research | Birmingham | Alabama | 35205 | — |
| Hope Clinical Research | Canoga Park | California | 91303 | — |
| Ark Clinical Research | Fountain Valley | California | 92708 | — |
| Ark Clinical Research | Long Beach | California | 90815 | — |
| Catalina Research Institute, LLC | Montclair | California | 91763 | — |
| Paradigm Clinical Research Centers, LLC | San Diego | California | 92108 | — |
| Southwest General Healthcare Center | Fort Myers | Florida | 33907 | — |
| Panax Clinical Research | Miami Lakes | Florida | 33014 | — |
| Clinical Site Partners, LLC dba Flourish Research | Winter Park | Florida | 32789 | — |
| David Kavtaradze MD, Inc | Cordele | Georgia | 31015 | — |
| Excel Clinical Research | Las Vegas | Nevada | 89109 | — |
| Diabetes and Endocrinology Associates of Stark County | Canton | Ohio | 44718 | — |
| Elligo Health Research, Inc. | Austin | Texas | 78704 | — |
| Zenos Clinical Research | Dallas | Texas | 75230 | — |
| Synergy Groups Medical | Houston | Texas | 77061 | — |
| Epic Clinical Research | Lewisville | Texas | 75057 | — |
| Synergy Group Medical LLC | Missouri City | Texas | 77459 | — |
| Manassas Clinical Research Center | Manassas | Virginia | 20110 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07502495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 28, 2026 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07502495 live on ClinicalTrials.gov.